{"id":"https://openalex.org/W2176306270","doi":"https://doi.org/10.1111/apt.13437","title":"Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea","display_name":"Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-30","ids":{"openalex":"https://openalex.org/W2176306270","doi":"https://doi.org/10.1111/apt.13437","mag":"2176306270","pmid":"https://pubmed.ncbi.nlm.nih.gov/26618924"},"language":"en","primary_location":{"id":"doi:10.1111/apt.13437","doi":"https://doi.org/10.1111/apt.13437","is_oa":false,"landing_page_url":"https://doi.org/10.1111/apt.13437","pdf_url":null,"source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2176306270"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034864639","display_name":"Mark Pimentel","orcid":"https://orcid.org/0000-0002-0619-5115","observed_orcids":["https://orcid.org/0000-0002-0619-5115"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. Pimentel","raw_affiliation_strings":["GI Motility Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GI Motility Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1282927834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034864639"],"corresponding_institution_ids":["https://openalex.org/I1282927834"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":1.7308,"has_fulltext":false,"cited_by_count":89,"citation_normalized_percentile":{"value":0.86746143,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"43","issue":"S1","first_page":"37","last_page":"49"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10066","display_name":"Gut microbiota and health","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13569","display_name":"Microscopic Colitis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifaximin","display_name":"rifaximin","score":1.0},{"id":"https://openalex.org/keywords/irritable-bowel-syndrome-with-diarrhea","display_name":"irritable bowel syndrome with diarrhea","score":0.9919999837875366},{"id":"https://openalex.org/keywords/gut-microbiota","display_name":"gut microbiota","score":0.9449999928474426},{"id":"https://openalex.org/keywords/small-intestinal-bacterial-overgrowth","display_name":"small intestinal bacterial overgrowth","score":0.9620000123977661},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.7059999704360962},{"id":"https://openalex.org/keywords/proinflammatory-response","display_name":"pro-inflammatory response","score":0.6140000224113464},{"id":"https://openalex.org/keywords/bacterial-fermentation","display_name":"bacterial fermentation","score":0.6620000004768372},{"id":"https://openalex.org/keywords/post-infectious-ibs","display_name":"post-infectious IBS","score":0.8019999861717224},{"id":"https://openalex.org/keywords/probiotics","display_name":"probiotics","score":0.8379999995231628},{"id":"https://openalex.org/keywords/microbial-diversity","display_name":"microbial diversity","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C2778889925","wikidata":"https://www.wikidata.org/wiki/Q416073","display_name":"Rifaximin","level":3,"score":0.9697853326797485},{"id":"https://openalex.org/C2778271842","wikidata":"https://www.wikidata.org/wiki/Q838966","display_name":"Irritable bowel syndrome","level":2,"score":0.939096212387085},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9325505495071411},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5467057824134827},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4879097640514374},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3652322292327881},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.10815766453742981},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069196","descriptor_name":"Gastrointestinal Microbiome","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000078262","descriptor_name":"Rifaximin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005243","descriptor_name":"Feces","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005285","descriptor_name":"Fermentation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007421","descriptor_name":"Intestine, Small","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D012294","descriptor_name":"Rifamycins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012294","descriptor_name":"Rifamycins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019468","descriptor_name":"Disease Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019936","descriptor_name":"Probiotics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D043183","descriptor_name":"Irritable Bowel Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D043183","descriptor_name":"Irritable Bowel Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D043183","descriptor_name":"Irritable Bowel Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/apt.13437","doi":"https://doi.org/10.1111/apt.13437","is_oa":false,"landing_page_url":"https://doi.org/10.1111/apt.13437","pdf_url":null,"source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:26618924","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26618924","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary pharmacology & therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320313996","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90"},{"id":"https://openalex.org/F4424624092","display_name":"Salix Pharmaceuticals","ror":"https://ror.org/01akhf054"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W1465481857","https://openalex.org/W1487811474","https://openalex.org/W1587016945","https://openalex.org/W1970324446","https://openalex.org/W1972248676","https://openalex.org/W1976118863","https://openalex.org/W1976224228","https://openalex.org/W1980174157","https://openalex.org/W1999133483","https://openalex.org/W1999969457","https://openalex.org/W2002324192","https://openalex.org/W2005429741","https://openalex.org/W2007435811","https://openalex.org/W2009348105","https://openalex.org/W2019442793","https://openalex.org/W2021385518","https://openalex.org/W2024601462","https://openalex.org/W2026317976","https://openalex.org/W2034001493","https://openalex.org/W2035174162","https://openalex.org/W2036988938","https://openalex.org/W2041093181","https://openalex.org/W2047740672","https://openalex.org/W2049004338","https://openalex.org/W2051060917","https://openalex.org/W2051086816","https://openalex.org/W2052266489","https://openalex.org/W2056304431","https://openalex.org/W2057169806","https://openalex.org/W2068581899","https://openalex.org/W2077005896","https://openalex.org/W2077623116","https://openalex.org/W2078752617","https://openalex.org/W2087956925","https://openalex.org/W2091756720","https://openalex.org/W2093676252","https://openalex.org/W2094665977","https://openalex.org/W2099360240","https://openalex.org/W2103771013","https://openalex.org/W2114437230","https://openalex.org/W2115895723","https://openalex.org/W2120356061","https://openalex.org/W2120896017","https://openalex.org/W2122386735","https://openalex.org/W2123812491","https://openalex.org/W2125894152","https://openalex.org/W2130488316","https://openalex.org/W2130745226","https://openalex.org/W2131486886","https://openalex.org/W2133926562","https://openalex.org/W2138196119","https://openalex.org/W2140728017","https://openalex.org/W2141397074","https://openalex.org/W2149216059","https://openalex.org/W2151028255","https://openalex.org/W2162911888","https://openalex.org/W2165023696","https://openalex.org/W2242808603","https://openalex.org/W2271932622","https://openalex.org/W2430285748","https://openalex.org/W2475088993"],"related_works":["https://openalex.org/W3001750915","https://openalex.org/W962900825","https://openalex.org/W2113472299","https://openalex.org/W2169328643","https://openalex.org/W2145345266","https://openalex.org/W2810071907","https://openalex.org/W2977822116","https://openalex.org/W3031465530","https://openalex.org/W4365453372","https://openalex.org/W1652108323"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,124],"role":[2,57,164],"of":[3,9,19,36,42,58,66,83,94,126,128,169,172,176,178,229],"gut":[4],"microbiota":[5,27],"in":[6,23,60,89,149,165,180,189,219,225],"the":[7,40,53,56,75,92,166,173,181,226],"pathophysiology":[8],"irritable":[10],"bowel":[11,79],"syndrome":[12],"(IBS)":[13],"is":[14],"supported":[15],"by":[16],"various":[17],"lines":[18],"evidence,":[20],"including":[21],"differences":[22],"mucosal":[24],"and":[25,32,39,45,62,81,222],"faecal":[26],"between":[28],"patients":[29,150,204],"with":[30,96,151,193,205],"IBS":[31,61,95,104],"healthy":[33],"individuals,":[34],"development":[35],"post-infectious":[37],"IBS,":[38],"efficacy":[41,199],"some":[43,154],"probiotics":[44],"nonsystemic":[46],"antibiotics":[47],"(e.g.":[48],"rifaximin).":[49],"AIM:":[50],"To":[51],"review":[52],"literature":[54,70],"regarding":[55],"rifaximin":[59,114,140,179,184,196,212],"its":[63],"potential":[64],"mechanism(s)":[65],"action.":[67],"METHODS:":[68],"A":[69],"search":[71],"was":[72,87],"conducted":[73],"using":[74],"terms":[76],"'rifaximin',":[77],"'irritable":[78],"syndrome'":[80],"'mechanism":[82],"action'.":[84],"RESULTS:":[85],"Rifaximin":[86],"approved":[88],"2015":[90],"for":[91],"treatment":[93,115],"diarrhoea.":[97],"In":[98,153],"contrast":[99],"to":[100,110,146,216],"other":[101],"currently":[102],"available":[103],"therapies":[105],"that":[106,119,139],"require":[107],"daily":[108],"administration":[109],"maintain":[111],"efficacy,":[112],"2-week":[113],"achieved":[116],"symptom":[117],"improvement":[118],"persisted":[120],"\u226512":[121],"weeks":[122],"post-treatment.":[123],"mechanisms":[125],"action":[127],"rifaximin,":[129],"therefore,":[130],"may":[131,141,161,185,214],"extend":[132],"beyond":[133],"direct":[134],"bactericidal":[135],"effects.":[136],"Data":[137],"suggest":[138],"decrease":[142,218],"host":[143],"proinflammatory":[144],"responses":[145],"bacterial":[147,158,220],"products":[148],"IBS.":[152,170,230],"cases,":[155],"small":[156,182],"intestinal":[157],"overgrowth":[159],"(SIBO)":[160],"play":[162],"a":[163,217,223],"clinical":[167,227],"symptoms":[168,228],"Because":[171],"high":[174],"level":[175],"solubility":[177],"intestine,":[183],"reset":[186],"microbial":[187,209],"diversity":[188,210],"this":[190,194],"environment.":[191],"Consistent":[192],"hypothesis,":[195],"has":[197],"antibiotic":[198],"against":[200],"isolates":[201],"derived":[202],"from":[203],"SIBO.":[206],"CONCLUSION:":[207],"Resetting":[208],"via":[211],"use":[213],"lead":[215],"fermentation":[221],"reduction":[224]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2176306270","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
